BriaCell Therapeutics Corp. Warrant (BCTXZ) Earnings History
Net Loss20 years of earnings data (2006–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
BriaCell Therapeutics Corp. Warrant (BCTXZ) Earnings Overview
As of June 30, 2026, BriaCell Therapeutics Corp. Warrant (BCTXZ) reported trailing twelve-month net income of -$31M, reflecting -44.1% year-over-year growth. The company earned $-4.23 per diluted share over the past four quarters.
Looking at the long-term picture, BCTXZ's historical earnings data spans multiple years. The company achieved its highest annual net income of -$8,581 in fiscal 2006.
BriaCell Therapeutics Corp. Warrant is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including NKTR (-$158M net income, -297.1% margin), ADCT (-$137M net income, -175.3% margin), SNDX (-$243M net income, -165.6% margin), BCTXZ has comparable earnings metrics. Compare BCTXZ vs NKTR →
BCTXZ Earnings vs Peers
Earnings metrics vs comparable public companies
BCTXZ Historical Earnings Data (2006–2025)
20 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$27M | -455.9% | -$28M | $-62.95 | - | - |
| 2024 | -$5M | +76.4% | -$33M | $-43.68 | - | - |
| 2023 | -$20M | +24.4% | -$23M | $-195.00 | - | - |
| 2022 | -$27M | -94.3% | -$15M | $-259.50 | - | - |
| 2021 | -$14M | -179.6% | -$7M | $-467.51 | - | - |
| 2020 | -$5M | +14.6% | -$5M | $-1038.19 | - | - |
| 2019 | -$6M | -7.0% | -$6M | $-1497.36 | - | - |
| 2018 | -$5M | -68.1% | -$5M | $-1799.26 | - | - |
| 2017 | -$3M | -45.4% | -$3M | $-1349.43 | - | - |
| 2016 | -$2M | +36.5% | -$2M | $-1349.95 | - | - |
| 2015 | -$3M | +60.8% | -$2M | $-2248.52 | - | - |
| 2014 | -$9M | -2239.4% | $-475,846 | $-21928.45 | - | - |
| 2013 | $-379,736 | +61.9% | $-288,415 | $-1461.86 | - | - |
| 2012 | $-996,797 | +3.1% | $-558,387 | $-2922.90 | - | - |
| 2011 | -$1M | -11.2% | -$1M | $-4387.51 | - | - |
| 2010 | $-925,560 | -276.2% | $-333,512 | $-7308.64 | - | - |
| 2009 | $-246,014 | -142.6% | $-251,454 | $-4381.91 | - | - |
| 2008 | $-101,388 | +18.2% | $-116,964 | $-2924.68 | - | - |
| 2007 | $-123,886 | -1343.7% | $-137,351 | $-4456.52 | - | - |
| 2006 | $-8,581 | - | $-8,581 | $-0.00 | - | - |
Download Data
Export BCTXZ earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
20+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
BCTXZ — Frequently Asked Questions
Quick answers to the most common questions about buying BCTXZ stock.
What is BCTXZ earnings per share (EPS)?
BCTXZ trailing twelve-month (TTM) diluted EPS is $-4.23, reflecting -44.1% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2006 to 2025 is available in the table on this page.
What is BriaCell Therapeutics Corp. Warrant's net income?
BriaCell Therapeutics Corp. Warrant (BCTXZ) trailing twelve-month net income is $-31M as of 2025. Earnings declined -44.1% year-over-year.
Is BCTXZ profitable?
BCTXZ is not currently profitable on a TTM basis, reporting a net loss of $-31M. Net margin is N/A. Investors should monitor for a return to profitability.
What is BCTXZ's earnings growth rate?
BCTXZ compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2006 to 2025.
What are BCTXZ's profit margins?
BriaCell Therapeutics Corp. Warrant net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -362.2%.
Is BCTXZ growing earnings?
BCTXZ earnings are declining — EPS fell -44.1% year-over-year. TTM net income dropped to $-31M. This contrasts with the 5-year CAGR of N/A.
What was BCTXZ's best earnings year?
BriaCell Therapeutics Corp. Warrant's highest annual net income on record is $-8581.00, achieved in fiscal year 2006. Earnings history on this page spans 2006 to 2025 and includes all annual and quarterly figures.
What were BCTXZ's earnings last quarter?
BCTXZ's most recent reported quarter was Q3 2026. Net income was $-7M with diluted EPS of $-0.99. For a full breakdown of all quarters, see the quarterly earnings table on this page.